Related Experiment Videos

Human tumors associated with Carney complex and germline PRKAR1A mutations: a protein kinase A disease!

Sotirios G Stergiopoulos1, Constantine A Stratakis

  • 1Section on Endocrinology and Genetics, Developmental Endocrinology Branch, National Institute of Child Health and Human Development, NIH, Building 10, Room 10N262, 10 Center Dr. MSC1862, Bethesda, MD 20892, USA.

FEBS Letters
|June 28, 2003
PubMed

Insights

Carney complex (CNC) is a rare genetic disorder causing various tumors. The PRKAR1A gene, linked to protein kinase A (PKA), is implicated in CNC and Cushing syndrome, highlighting cAMP pathway

Area of Science:

  • Endocrinology
  • Genetics
  • Oncology

Background:

  • Carney complex (CNC) is a rare multiple neoplasia syndrome.
  • Primary pigmented nodular adrenocortical disease (PPNAD) is the most common endocrine manifestation of CNC and the only known inherited form of Cushing syndrome.

Purpose of the Study:

  • To review Carney complex (CNC).
  • To discuss the implications of genetic discoveries for the cAMP and/or protein kinase A (PKA) pathway's role in human tumorigenesis.

Main Methods:

  • Literature review of Carney complex (CNC) and related genetic research.
  • Identification of chromosomal loci associated with CNC.
  • Analysis of the PRKAR1A gene and its role in the cAMP signaling pathway.

Main Results:

  • Two chromosomal loci were identified for CNC.
  • The PRKAR1A gene, encoding the RIalpha subunit of PKA, was found at locus 17q22-24.
  • PRKAR1A is a critical component of the cAMP signaling pathway.

Conclusions:

  • The discovery of PRKAR1A implicates the cAMP and/or PKA pathway in CNC pathogenesis.
  • This finding provides insights into the molecular mechanisms underlying CNC and potentially other human tumors.
  • Further research into the cAMP/PKA pathway is warranted for understanding and treating CNC and related conditions.

Related Concept Videos